Upper-Room Germicidal UV
SaniLume
The only Canadian-made, Health Canada-registered Upper-Room GUV in Canada. University of Leeds validated. 201–1,994 eACH, 99.7% pathogen kill, 166× the CDC recommendation.
Health Canada registered
Engineered for occupied spaces
Fan-integrated, Canadian-made, Health Canada-registered for continuous operation while rooms are in use.
201–1,994 eACH
166× the CDC recommendation
University of Leeds validated, the best-performing upper-room UV device tested.
The Invisible Threat
Airborne Pathogens Spread in Seconds.
When an infected person exhales, coughs, or sneezes, pathogen-laden aerosols spread throughout the room in minutes. Without intervention, everyone in the space is at risk.
- 01
Rapid Transmission
Airborne pathogens can travel 6+ meters and remain infectious for hours. A single infected person can expose an entire room within minutes.
- 02
Behavioral Compliance Fails
Masks, distancing, and ventilation depend on human behavior. Compliance drops over time. Infrastructure-based solutions work 24/7.
- 03
SaniLume Solution
The UVC energy field continuously neutralizes pathogens in the upper room zone. Air is disinfected as it naturally circulates, protecting everyone below.
The Technology
What is Upper-Room GUV?
A CDC-endorsed technology that uses germicidal ultraviolet light to continuously disinfect air in occupied spaces, without exposing people to harmful UV radiation.
Continuous Air Disinfection While You Work.
Upper-room germicidal ultraviolet (GUV) systems use 254 nm UVC light to destroy airborne pathogens including bacteria, viruses, and fungi. The technology has been proven effective against tuberculosis, influenza, measles, and SARS-CoV-2.
Unlike portable air purifiers or HVAC filters, upper-room GUV provides continuous, real-time disinfection at the point of transmission. Pathogens are destroyed within seconds of becoming airborne, before they can reach another person.
The key innovation: UV fixtures are mounted near the ceiling and direct germicidal light into the upper-room zone, above head height. Natural air convection continuously cycles room air through this disinfection zone, while keeping people safely below.
SaniLume takes this further with active air circulation that dramatically increases the rate of air exchange through the UV zone, achieving performance 83–200× better than passive devices.
World-Leading Performance
The Numbers Speak for Themselves.
University of Leeds testing validates SaniLume as the "best performing UV device tested to date."
201–1,994 Equivalent Air Changes per Hour
CDC recommends 6–12 ACH for healthcare.
What Does 201–1,994 eACH Mean?
Equivalent Air Changes per Hour (eACH) measures how effectively a device removes pathogens from the air. It represents the pathogen reduction equivalent to completely replacing the room’s air that many times per hour.
The CDC recommends 6–12 air changes per hour for healthcare infection control. Typical upper-room GUV devices achieve 10–24 eACH. SaniLume achieves 201–1,994 eACH depending on room geometry and configuration — up to 166× the CDC recommendation and well above the performance of typical devices.
This isn’t a marginal improvement. This is a fundamentally different category of performance.
- 99.7% Pathogen Elimination Rate
- 750 Square Feet Coverage
- 24 Day Hospital Payback
- Only Canadian Health Registered
Proven Science
Research-Backed Efficacy.
Upper-room GUV is endorsed by the CDC, WHO, and ASHRAE. Published research demonstrates significant pathogen reduction.
- PLoS Medicine
Escombe et al. TB Study
Landmark study demonstrating upper-room GUV effectiveness in real-world healthcare settings with drug-resistant tuberculosis patients.
70%
TB transmission reduction
- Hospital Isolation Study 2023
SARS-CoV-2 Inactivation
Upper-room UVGI achieved rapid inactivation of SARS-CoV-2 virus at low irradiance levels in hospital isolation rooms.
90–99%
virus disinfection
- CDC/NIOSH Guidance
Healthcare Implementation
CDC endorses upper-room GUV as a supplemental air cleaning technology for healthcare facilities and high-risk settings.
10–24
eACH typical devices
SaniLume vs. Devices Used in Published Research
10–24
eACH, typical GUV devices in landmark studies.
vs
201–1,994
eACH, SaniLume.
83–200× more effective. If those devices achieved 70–99% pathogen reduction, imagine what SaniLume delivers.
Active Technology
How SaniLume Works.
Unlike passive devices that hope air circulates through the UV zone, SaniLume actively moves air for guaranteed performance.
- 01
Active Air Intake
Integrated fans draw contaminated room air into the device at a controlled rate, not relying on passive convection.
- 02
UVC Exposure
Air passes through an intense 254 nm germicidal UV zone, destroying DNA/RNA of pathogens within seconds.
- 03
Pathogen Destruction
99.7% of bacteria, viruses, and fungi are eliminated, including antibiotic-resistant strains and airborne viruses.
- 04
Clean Air Return
Disinfected air is returned to the room, creating continuous circulation that protects occupants 24/7.
The signature performance
166× the CDC baseline.
Not marginal improvement. A different category of air disinfection altogether, engineered, validated, Health Canada registered.
- Up to 1,994
eACH - 99.7%
Pathogen kill - Made in Canada
Health Canada-registered
Competitive Advantage
Why SaniLume Dominates.
Head-to-head comparison with traditional upper-room GUV devices from major competitors, Signify, Atlantic UV, Xenex, Tru-D.
| Metric | Traditional GUV | SaniLume |
|---|---|---|
| Pathogen Reduction | 5–74% | 99.7% |
| Equivalent Air Changes | 0.003–17 eACH | 201–1,994 eACH |
| Air Movement Method | Passive (Hope-Based) | Active (Engineered) |
| Coverage Area | 125–400 sq ft | 750 sq ft |
| Health Canada Certified | No | Yes (Only One) |
| Canadian Made | No (Imported) | 100% Ottawa |
Why Passive GUV Fails
Industry-Leading Performance
| Traditional Approach | SaniLume Solution |
|---|---|
| Air Circulation Method | Wait for natural convection |
| Disinfection Certainty | Hope air passes through |
| vs CDC Recommendation | 1–2× CDC target |
| Regulatory First-Mover | No HC registration |
| Tariff Exposure | Subject to import duties |
The scale of the problem
The Global Healthcare-Associated Infection Crisis.
Healthcare-associated infections kill more people than car accidents, diabetes, or influenza. The problem is global, the solution is proven, and the market is massive.
| United States | Canada | Global | |
|---|---|---|---|
| HAI Deaths Annually | 33,000 | 33,151 | 700,000+ |
| Annual Direct Cost | $29B | $29.3B | |
| HAI Infections / Year | 1.7M | 473,590 | 7M+ |
| Hospitals | 6,000+ |
Market Opportunity
A regulatory tailwind & an $82B market.
- $82B Global HAI Control Market by 2033
- $3.2B+ Canadian Addressable Market (CHAIR)
- 24 Days Average Hospital Payback Period
- 65–70% SaniLume Gross Margins
Canadian Market
Addressable Market Opportunity.
$3.2B+ addressable market in Canada alone. CSA mandates and liability concerns are driving immediate adoption.
- 1,000+ Hospitals
- 2,000+ LTC Facilities
- 15,500+ Schools
- 5,000+ Gov't Buildings
The Business Case
Medical Device Economics.
SaniLume delivers rapid customer payback with the regulatory moats, Canadian manufacturing, and unmatched performance that create a sustainable competitive advantage.
| Unit Economics | |
|---|---|
| sq ft Coverage | 750 |
| Hospital Payback | 24 Days |
| Annual eACH | 201–1,994 |
Hospital ROI
| CHAIR Projection | |
|---|---|
| SaniLume Unit Cost | $3,500 CAD |
| Installation | $500 |
| Total Investment | $4,000 |
| HAI Cost Avoided (Annual) | $61,000+ |
| Annual ROI | 44,741% |
| Payback Period | 24 Days |
A $4,000 investment pays back in 24 days on HAI cost avoidance alone. Every year after is pure savings.
Applications
Where SaniLume Protects.
Any indoor environment where airborne pathogen transmission is a concern. Critical for healthcare, education, and high-traffic public spaces.